Quality of Life in Patients with Tumors of the Nervous System and the Type and Location of the Tumor
Keywords
quality of life, brain tumor, tumor of the spineAbstract
Background. Cancer disease of nervous system is characterized by non-specific symptoms, variable ethiology and persistence. The side-effect in this illness may cause a decrease in quality of life.
Aim. Recognition and estimation of life quality of patients with cancer (neoplasm) disease of nervous system, who are treated by neurosurgical methods, and identification of factors determining this state.
Material and methods. Group of patients numbered 54 ailing with cancer (neoplasm) disease of nervous system diagnosed treated by neurosurgical methods. Evaluation material were gathered by standardized questionnaire WHOQOL – BREF, with metric system, invented to evaluate the quality of life. Above mentioned data was supplemented by the analysis of medical documentation. Gathered material were statistically developed and verified on the level of importance p=0,05.
Results. 38 people, which is 70,4%, evaluated their quality of life positively while 5 people, which is 9,3%, negatively. However, satisfaction from health were even on all three marks, 18 people (33,3%) each. From the physical point of view, 24 people (44,4%), presented positive opinions.
Conclusions. 1. Patients evaluate their quality of life and satisfaction of health fairly high. However they are more satisfied with their quality of life more than live their health. 2. The level of quality of live is influenced by the kind of cancer; the patients with brain cancer have higher quality of live and shows higher satisfaction with their health. (PNN 2013;2(4):140-148)
References
Chrobak M. Ocena jakości życia zależnej od stanu zdrowia. Problemy Pielęgniarstwa. 2009;17(2): 123-126.
Kuśnierkiewicz M., Wierzbicka M., Wojtowicz J.G. Psychologiczne aspekty leczenia chorych z nowotworami głowy i szyi. Otolar Pol. 2001;LV(2):169-173.
Wrońska I., Stępień R., Witaszka G. Jakość życia w naukach medycznych (część I). Pielęg XX w.2004;1(6):5-8.
Trzebiatowski J. Jakość życia w perspektywie nauk społecznych i medycznych – systematyzacja ujęć definicyjnych. Hygeia Public Health. 2011;46(1):25-31.
Jaskólski D., Liberski P., Michalak S. Nowotwory ośrodkowego układu nerwowego i neurologiczne zespoły paranowotworowe. W: Kozubski W., Liberski P. (Red.), Neurologia. PZWL, Warszawa 2008;468-498.
Mehta M., Vogelbaum M.A., Chang S., et al. Neoplasms of the central nervous system. In DeVita V.T. Jr., Lawrence T.S., Rosenberg S.A. (Eds.), Cancer: Principles and Practice of Oncology. Lippincott Williams & Wilkins, Philadelphia 2011;1700-1749.
Ferlay J., Shin H.R., Bray F., et al. GLOBOCAN 2008: Cancer Incidence and Mortality Worldwide in 2008. IARC Prasa, Francja-Lyon 2010.
Wojciechowska U., Dzikowska J., Zatoński W. Nowotwory złośliwe w Polsce w 2010 roku. Centrum Onkologii Instytut, Warszawa 2012.
Altekruse S.F, Kosary C.L., Krapcho M., et al. SEER Cancer Statistics Review, 1975-2007. National Cancer Institute, Bethesda 2010.
Nowacki P. Zarys epidemiologii guzów ośrodkowego układu nerwowego. Pol Prz Neurol. 2007;3(3):142-144.
Wołowicka L. Jakość życia w naukach medycznych. Akademia Medyczna w Poznaniu, Poznań 2001.
Ware J.E. SF-36 health survey update. Spine. 2000;25(24):3130-3139.
McMurray A., Grant S., Griffiths S., Letford A. Health-related quality of life and health service use following total hip replacement surgery. J Adv Nurs. 2002;40(6):663-672.
Topór-Mądry R. Choroby przewlekłe: obciążenie, jakość życia i konsekwencje ekonomiczne. Zdr Publ Zarz. 2011;9(1):25-49.
Klein M., Heimans J.J., Aaronson N.K., et al. Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet. 2002;360:1361-1368.
Pignatti F., van den Bent M., Curran D., et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol. 2002;20:2076-2084.
Rosińczuk-Tonderys J., Żerkowska U., Całkosiński I., Olkowska L. Ocena problemów dnia codziennego pacjentów z guzem mózgu poddanych radioterapii i chemioterapii. PNN. 2012;1(1):4-9.
Chen L., Zou X., Wang Y., Mao Y., Zhou L. Central nervous system tumors: a single center pathology review of 34,140 cases over 60 years. BMC Clinical Patology. 2013;13:14.
Baldi I., Gruber A., Alioum A., et al. Descriptive epidemiology of CNS tumors in France: results from the Gironde Registry for the period 2000-2007. Neuro Oncol. 2011;13(12):1370-1378.
Gavrilovic I.T., Posner J.B. Brain metastases: epidemiology and pathophysology. J Neurooncol. 2005;75(1):514.
Patchell R.A. The management of brain metastases. Cancer Treat Rev. 2003;29(6):533-540.
Klein M., Taphoorn M.J., Heimans J.J., et al. Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients. J Clin Oncol. 2001;19:4037-4047.
Brown P.D., Ballman K.V., Rummans T.A., et al. Prospective study of quality of life in adults with newly diagnosed high-grade gliomas. J Neurooncol. 2006;76:283-291.
Taphoorn M.J., Stupp R., Coens C., et al. Health-related quality of life in patients with glioblastoma: A randomised controlled trial. Lancet Oncol. 2005;6:937-944.
Taphoorn M.J., Sizoo E.M., Bottomley A. Review on Quality of Life Issues in Patients with Primary Brain Tumors. The Oncologist. 2010;15(6):618-626.
Quan G., Vital J.M., Aurouer N., et al. Surgery improves pain, function and quality of life in patients with spinal metastases: a prospective study on 118 patients. Eur Spine J. 2011;20(11):1970-1978.
Wolny E., Miszczyk L., Tukiendorf A. Ocena skuteczności różnych metod radioterapii przerzutów raka płuca do mózgu. Współcz Onkol. 2005;9(8)342-346.
Modlińska A, Buss T, Krakowiak P. Ocena jakości życia osób w wieku podeszłym w terminalnym okresie choroby nowotworowej. Przegląd Lekarski. 2009;66:479-84.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Stats
Number of views and downloads: 181
Number of citations: 0